← All candidates
Two insider buys in the last year — $161.2K in all.
36 filings on record.
STIMNeuronetics, Inc.
NasdaqGM · Healthcare · $210.30M
$2.76
-1.43% · Sep 16
Two insider buys in the last year — $161.2K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 2 buys● 6 sells◆ 8 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$210.30M
Float
37.2M
49% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
1.4
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
Chernett Jorey
Bought $117.0K on May 19 — 100,000 sh @ $1.17, held direct, 0.9% of their stake.
1 of 1 position beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
31 more transactions on Pro →Context
Wall St
$4.50 avg target
+63.0% vs today · 4 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 5 quarters beat
Q2 '26−$0.04 act+$0.08
Q1 '26−$0.15 act+$0.03
Q4 '25−$0.10 act+$0.01
Q3 '25−$0.13 act−$0.01
The file stays open
36 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice